Agilon Health (NYSE:AGL) Shares Down 9.5% - Time to Sell?

Agilon Health logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Agilon Health shares fell 9.5% in mid-day trading to about $104.28, on volume 91% below its average.
  • Analyst views are mixed: the consensus rating is Hold, with an average price target of $107.38; ratings include seven Buys, six Holds, two Sells, and one Strong Buy.
  • The company beat quarterly EPS and revenue estimates, reporting $1.97 per share and $1.52 billion in revenue, but still posted a negative net margin and return on equity; analysts forecast a full-year loss.
  • Five stocks we like better than Agilon Health.

Agilon Health, Inc. (NYSE:AGL - Get Free Report) was down 9.5% during mid-day trading on Wednesday. The stock traded as low as $104.06 and last traded at $104.2770. 27,812 shares were traded during mid-day trading, a decline of 91% from the average daily volume of 314,814 shares. The stock had previously closed at $115.20.

Wall Street Analysts Forecast Growth

AGL has been the subject of several analyst reports. Benchmark reissued a "buy" rating and issued a $140.00 price target (up from $95.00) on shares of Agilon Health in a report on Thursday, August 6th. Royal Bank Of Canada set a $125.00 price target on shares of Agilon Health in a report on Tuesday, September 15th. Sanford C. Bernstein upgraded Agilon Health from a "market perform" rating to an "outperform" rating and increased their price objective for the stock from $86.00 to $125.00 in a research report on Tuesday, September 15th. Barclays set a $111.00 price objective on Agilon Health and gave the company an "equal weight" rating in a research note on Thursday, August 6th. Finally, Citigroup upgraded Agilon Health from a "sell" rating to a "neutral" rating and boosted their target price for the stock from $105.00 to $115.00 in a research report on Monday, August 10th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $107.38.

Check Out Our Latest Research Report on Agilon Health

Agilon Health Trading Down 16.1%

The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.13 and a current ratio of 1.13. The firm has a market cap of $1.62 billion, a PE ratio of -17.39 and a beta of 3.10. The stock's 50 day simple moving average is $91.75 and its 200 day simple moving average is $69.93.

Agilon Health (NYSE:AGL - Get Free Report) last issued its quarterly earnings results on Wednesday, November 4th. The company reported $1.97 EPS for the quarter, topping analysts' consensus estimates of ($1.23) by $3.20. Agilon Health had a negative net margin of 1.45% and a negative return on equity of 51.97%. The firm had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.46 billion. On average, sell-side analysts forecast that Agilon Health, Inc. will post -1.87 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Goldman Sachs Group Inc. bought a new position in Agilon Health during the third quarter valued at approximately $52,206,000. State Street Corp lifted its holdings in shares of Agilon Health by 16.4% in the 3rd quarter. State Street Corp now owns 326,157 shares of the company's stock worth $25,959,000 after acquiring an additional 46,031 shares during the last quarter. Marshall Wace LLP bought a new stake in shares of Agilon Health in the 3rd quarter worth approximately $22,141,000. Rubicon Founders LLC bought a new stake in shares of Agilon Health in the 2nd quarter worth approximately $11,290,448. Finally, Bank of New York Mellon Corp boosted its stake in shares of Agilon Health by 9.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 35,336 shares of the company's stock valued at $3,787,000 after purchasing an additional 3,074 shares in the last quarter.

Agilon Health Company Profile

(Get Free Report)

Agilon Health is a U.S. healthcare company that partners with primary care physicians to provide care for patients enrolled in Medicare Advantage plans. Its model is designed to help physician groups move from traditional fee-for-service care toward value-based care, in which providers are rewarded for improving patients' health and coordinating their care. The company provides participating physician groups with clinical, operational, technology and administrative support, along with resources to manage patient populations and coordinate care across local healthcare networks.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Agilon Health Right Now?

Before you consider Agilon Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.

While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines